| Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline. NF Voelkel, RM Tuder, J Bridges, WP Arend American journal of respiratory cell and molecular biology 11 (6), 664-675, 1994 | 268 | 1994 |
| ERdj4 and ERdj5 are required for endoplasmic reticulum-associated protein degradation of misfolded surfactant protein C M Dong, JP Bridges, K Apsley, Y Xu, TE Weaver Molecular biology of the cell 19 (6), 2620-2630, 2008 | 197 | 2008 |
| Pulmonary surfactant proteins A and D are potent endogenous inhibitors of lipid peroxidation and oxidative cellular injury JP Bridges, HW Davis, M Damodarasamy, Y Kuroki, G Howles, DY Hui, ... Journal of Biological Chemistry 275 (49), 38848-38855, 2000 | 195 | 2000 |
| Expression of a human surfactant protein C mutation associated with interstitial lung disease disrupts lung development in transgenic mice JP Bridges, SE Wert, LM Nogee, TE Weaver Journal of Biological Chemistry 278 (52), 52739-52746, 2003 | 186 | 2003 |
| LPCAT1 regulates surfactant phospholipid synthesis and is required for transitioning to air breathing in mice JP Bridges, M Ikegami, LL Brilli, X Chen, RJ Mason, JM Shannon The Journal of clinical investigation 120 (5), 1736-1748, 2010 | 160 | 2010 |
| Adenosine A2A receptor is a unique angiogenic target of HIF-2α in pulmonary endothelial cells A Ahmad, S Ahmad, L Glover, SM Miller, JM Shannon, X Guo, ... Proceedings of the National Academy of Sciences 106 (26), 10684-10689, 2009 | 158 | 2009 |
| Respiratory epithelial cell responses to SARS-CoV-2 in COVID-19 JP Bridges, EK Vladar, H Huang, RJ Mason Thorax 77 (2), 203-209, 2022 | 154 | 2022 |
| Segmental regulation of pulmonary vascular permeability by store-operated Ca2+ entry PM Chetham, P Babál, JP Bridges, TM Moore, T Stevens American Journal of Physiology-Lung Cellular and Molecular Physiology 276 (1 …, 1999 | 149 | 1999 |
| Lung Gene Expression Analysis (LGEA): an integrative web portal for comprehensive gene expression data analysis in lung development Y Du, JA Kitzmiller, A Sridharan, AK Perl, JP Bridges, RS Misra, ... Thorax 72 (5), 481-484, 2017 | 140 | 2017 |
| Adaptation and increased susceptibility to infection associated with constitutive expression of misfolded SP-C JP Bridges, Y Xu, CL Na, HR Wong, TE Weaver The Journal of cell biology 172 (3), 395-407, 2006 | 135 | 2006 |
| The alveolar epithelium determines susceptibility to lung fibrosis in Hermansky-Pudlak syndrome LR Young, PM Gulleman, JP Bridges, TE Weaver, GH Deutsch, ... American journal of respiratory and critical care medicine 186 (10), 1014-1024, 2012 | 108 | 2012 |
| Peroxisomal β-oxidation regulates whole body metabolism, inflammatory vigor, and pathogenesis of nonalcoholic fatty liver disease ME Moreno-Fernandez, DA Giles, TE Stankiewicz, R Sheridan, R Karns, ... JCI insight 3 (6), 2018 | 91 | 2018 |
| A novel triple-mutant AAV6 capsid induces rapid and potent transgene expression in the muscle and respiratory tract of mice LP van Lieshout, JM Domm, TN Rindler, KL Frost, DL Sorensen, ... Molecular Therapy-Methods & Clinical Development 9, 323-329, 2018 | 85 | 2018 |
| Orphan G protein–coupled receptor GPR116 regulates pulmonary surfactant pool size JP Bridges, MG Ludwig, M Mueller, B Kinzel, A Sato, Y Xu, JA Whitsett, ... American journal of respiratory cell and molecular biology 49 (3), 348-357, 2013 | 83 | 2013 |
| Secretion of surfactant protein C, an integral membrane protein, requires the N-terminal propeptide JJ Conkright, JP Bridges, CL Na, WF Voorhout, B Trapnell, SW Glasser, ... Journal of Biological Chemistry 276 (18), 14658-14664, 2001 | 81 | 2001 |
| Ca (2+)-inhibitable adenylyl cyclase and pulmonary microvascular permeability PM Chetham, HA Guldemeester, N Mons, GH Brough, JP Bridges, ... American Journal of Physiology-Lung Cellular and Molecular Physiology 273 (1 …, 1997 | 74 | 1997 |
| Statin as a novel pharmacotherapy of pulmonary alveolar proteinosis C McCarthy, E Lee, JP Bridges, A Sallese, T Suzuki, JC Woods, ... Nature communications 9 (1), 3127, 2018 | 72 | 2018 |
| Insulin-like growth factor 1 supports a pulmonary niche that promotes type 3 innate lymphoid cell development in newborn lungs K Oherle, E Acker, M Bonfield, T Wang, J Gray, I Lang, J Bridges, ... Immunity 52 (2), 275-294. e9, 2020 | 71 | 2020 |
| Targeting cholesterol homeostasis in lung diseases A Sallese, T Suzuki, C McCarthy, J Bridges, A Filuta, P Arumugam, ... Scientific reports 7 (1), 10211, 2017 | 69 | 2017 |
| Pathobiological pseudohypoxia as a putative mechanism underlying myelodysplastic syndromes Y Hayashi, Y Zhang, A Yokota, X Yan, J Liu, K Choi, B Li, G Sashida, ... Cancer discovery 8 (11), 1438-1457, 2018 | 58 | 2018 |
Francis X. McCormackDivision of Pulmonary, Critical Care and Sleep Medicine, The University of CincinnatiVerified email at uc.edu
